Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis.

Journal of gynecologic oncology - 1 Nov 2025

Lee Young-Jae, Kim Na-Eun, Bae Jung-Hyun, Sung Chang-Ohk, Lee Shin-Wha, Kim Dae-Yeon, Kim Yong-Man

Abstract excerpt

OBJECTIVE: We aimed to identify the main oncogenic pathway by histological type of ovarian cancer based on Next-generation sequencing (NGS) test and to determine the correlation with clinical prognosis. METHODS: We conducted a retrospective review of 420 patients with ovarian cancer who underwent NGS testing at Asan Medical Center from June 1, 2017, to May 31, 2021. Identified mutations were categorized into...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Cystadenocarcinoma, Serous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Ovarian Neoplasms

Share to Prognosis

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 40613115
DOI: 10.3802/jgo.2025.36.e128
PMCID: PMC12636105

Genes

TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis.PMID 40613115Read ↗

The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes.Semantic proximity Read ↗

Integrated genomic and histopathological analysis of low grade serous ovarian carcinoma identifies clinically distinct disease subtypesSemantic proximity Read ↗

Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities.Semantic proximity Read ↗

Clinicogenomic Landscape of Histologic Subtypes in Ovarian Cancer: Real-World Evidence From a Japanese Nationwide Cohort.Semantic proximity Read ↗

Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.Semantic proximity Read ↗

Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian CancerSemantic proximity Read ↗

MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma.Semantic proximity Read ↗

Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survivalSemantic proximity Read ↗

The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approaches.Semantic proximity Read ↗

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome.Semantic proximity Read ↗

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcomeSemantic proximity Read ↗

Rethinking ovarian cancer III: the past decade and future directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.